Command
3 screensSign in securely
MFA enforced • Device trust required • Session 15 min • All access is audit logged
Command overview
Real-time platform health across testing, lab, AI and marketplace.
| Queue | Volume | Ageing | Owner | State |
|---|---|---|---|---|
| Results awaiting clinical review | 184 | 6h avg | Clinical | Within SLA |
| Samples in transit | 96 | 1.2h avg | Logistics | Healthy |
| Recollection required | 7 | 18h avg | Lab | Escalated |
| Marketplace fulfilment | 212 | 4h avg | Partners | Healthy |
Live operations
Today across Abu Dhabi and Dubai.
| Collector | Zone | Assigned | Done |
|---|---|---|---|
| A. Rahman | Dubai Marina | 9 | 7 |
| F. Khalid | Downtown | 8 | 6 |
| M. Yusuf | Al Reem | 11 | 9 |
| S. Prakash | Khalifa City | 7 | 7 |
Users
4 screensUser directory
12,480 members across the UAE.
| Member | Plan | Assessments | Twin score | Last activity |
|---|---|---|---|---|
| Sarah Al Mansouri | Intelligence | 4 | 82 | Today |
| Omar Haddad | Core | 2 | 74 | 2 days |
| Layla Nasser | Intelligence | 6 | 68 | Today |
| Daniel Ferreira | Core | 1 | 79 | 5 days |
| Hessa Al Suwaidi | Longevity | 8 | 61 | 12 days |
User 360 — Sarah Al Mansouri
Clinical, operational and commercial context in one view.
| Activity | Type | Date | Status |
|---|---|---|---|
| Complete Biological Assessment | Lab order | 14 Aug | Published |
| Vitamin D3 + K2 | Marketplace | 09 Aug | Delivered |
| Vitamin D retest | Scheduled | 01 Sep | Pending |
| Oura connection | Wearable | 03 Mar | Active |
Consent & access
Every data category, versioned and revocable.
| Category | State | Policy version | Granted | Last change |
|---|---|---|---|---|
| Health data | Granted | v2.1 | 12 Jan 2026 | — |
| Genetic information | Granted | v2.1 | 12 Jan 2026 | — |
| Wearable data | Granted | v2.2 | 03 Mar 2026 | — |
| AI analysis | Granted | v2.2 | 03 Mar 2026 | — |
| Research participation | Withdrawn | v2.3 | — | 18 Jun 2026 |
Note — Withdrawal propagates to analytics, AI training exclusion lists and partner sharing within 24 hours.
Segments
Behavioural and biological cohorts for clinical and growth teams.
| Segment | Members | Definition | Owner |
|---|---|---|---|
| Vitamin D deficient | 3182 | 25-OH < 20 ng/mL | Clinical |
| Retest due 30 days | 2044 | Protocol retest window | Growth |
| Wearable connected | 7914 | ≥1 device authorised | Product |
| Corporate wellness | 1860 | Employer programme | Partnerships |
| Longevity plan | 612 | Plan = Longevity | Growth |
Catalogue
4 screensTest catalogue
48 tests, 12 panels, 6 packages.
| Test | Category | Markers | Price | TAT |
|---|---|---|---|---|
| Complete Biological Assessment | Comprehensive | 167 | AED 2,580 | 72h |
| Core Biology Panel | Essentials | 64 | AED 1,290 | 48h |
| Hormone Intelligence | Hormones | 22 | AED 990 | 72h |
| Genomic Foundation | Genetics | — | AED 3,400 | 21 days |
Test editor
Content, biology and commercial configuration in one record.
Plain-language description, biology explainer, preparation guidance and result expectations are authored here and versioned. Every publish requires clinical sign-off before it reaches the app.
Panels & packages
Bundles engineered for retesting cadence and margin.
| Package | Includes | Price | Margin | Cadence |
|---|---|---|---|---|
| Foundation Year | 4× Core Panel | AED 4,290 | 61% | Quarterly |
| Longevity Program | 2× Complete + Genomics | AED 8,600 | 56% | Bi-annual |
| Performance | Hormones + Recovery | AED 2,180 | 63% | Quarterly |
| Corporate Baseline | Core panel per employee | AED 890 | 48% | Annual |
Pricing & promotions
Controlled discounting with margin guardrails.
| Promotion | Type | Value | Usage | Status |
|---|---|---|---|---|
| Founding member | Percentage | 20% | 1,204 | Active |
| Corporate baseline | Fixed | AED 200 | 860 | Active |
| Retest loyalty | Percentage | 15% | 3,110 | Review |
Orders
3 screensOrder management
End-to-end order lifecycle with lab and logistics state.
| Order | Member | Test | Value | State |
|---|---|---|---|---|
| GQ-48219 | Sarah Al Mansouri | Complete Assessment | AED 2,580 | Published |
| GQ-48220 | Omar Haddad | Core Panel | AED 1,290 | In lab |
| GQ-48221 | Layla Nasser | Hormone Intelligence | AED 990 | Collected |
| GQ-48222 | Daniel Ferreira | Core Panel | AED 1,290 | Recollection |
Order GQ-48219
Single source of truth from checkout to published result.
Payments & refunds
UAE gateway reconciliation and dispute handling.
| Transaction | Method | Amount | State |
|---|---|---|---|
| TXN-99120 | Apple Pay | AED 2,580 | Captured |
| TXN-99121 | Visa | AED 1,290 | Captured |
| TXN-99122 | Mada | AED 990 | Failed |
| TXN-99123 | Visa | AED 1,290 | Refund pending |
Collection
4 screensCollection board
Home phlebotomy scheduling across emirates.
| Slot | Member | Zone | Collector | State |
|---|---|---|---|---|
| 07:00–07:30 | Sarah Al Mansouri | Dubai Marina | A. Rahman | Completed |
| 07:30–08:00 | Omar Haddad | Downtown | F. Khalid | Completed |
| 08:00–08:30 | Layla Nasser | Al Reem | M. Yusuf | En route |
| 08:30–09:00 | Daniel Ferreira | JLT | A. Rahman | Scheduled |
| 09:00–09:30 | Hessa Al Suwaidi | Khalifa City | — | Unassigned |
Collector dispatch
Assignment engine balancing zone, load and skill.
Route optimisation
Reduce travel time, protect sample integrity windows.
Collector performance
Quality, punctuality and member experience.
| Collector | Collections | On time | Recollection rate | Rating |
|---|---|---|---|---|
| A. Rahman | 214 | 98% | 0.4% | 4.9 |
| S. Prakash | 198 | 97% | 0.6% | 4.9 |
| M. Yusuf | 176 | 91% | 2.1% | 4.5 |
| F. Khalid | 164 | 96% | 0.9% | 4.8 |
Laboratory
6 screensLab workflow
Accessioning to validated result at the Abu Dhabi facility.
| Sample | Order | Stage | Age | Analyst |
|---|---|---|---|---|
| SMP-771204 | GQ-48219 | Published | — | Dr. N. Haddad |
| SMP-771205 | GQ-48220 | Analysis | 9h | Bench 3 |
| SMP-771206 | GQ-48222 | Recollection | 18h | QC |
| SMP-771207 | GQ-48221 | Validation | 4h | Dr. R. Aziz |
LIMS / FHIR integration
Bi-directional interface with the laboratory information system.
Note — Every ingested result is stored immutably with its source message for traceability and clinical audit.
Result import
Batch ingestion, validation and exception handling.
| Batch | Source | Records | Validated | Exceptions |
|---|---|---|---|---|
| BATCH-2291 | LIMS FHIR | 412 | 412 | 0 |
| BATCH-2292 | LIMS FHIR | 388 | 386 | 2 |
| BATCH-2293 | Partner lab CSV | 96 | 88 | 8 |
Clinical review
No result reaches a member without clinical approval.
| Marker | Value | Range | Flag |
|---|---|---|---|
| Vitamin D (25-OH) | 18 ng/mL | 30–50 | Low |
| Zinc | 68 µg/dL | 70–120 | Low |
| LDL cholesterol | 138 mg/dL | <100 | Elevated |
| hs-CRP | 0.8 mg/L | <1.0 | Optimal |
Abnormal flags
Escalation rules for critical and out-of-range values.
| Rule | Trigger | Action | SLA |
|---|---|---|---|
| Critical value | Outside critical bounds | Immediate clinician call | 30 min |
| Severe deficiency | Vitamin D < 12 ng/mL | Priority review + protocol | 4 h |
| Trend deterioration | 3 consecutive declines | Flag for review | 24 h |
| Sample quality | Haemolysis index high | Recollection request | 12 h |
Turnaround analytics
Where hours are won and lost.
Intelligence
6 screensAI governance
Every insight is versioned, explainable and clinically owned.
Model registry
Versioned models with clinical sign-off history.
| Model | Purpose | Version | Approved by | State |
|---|---|---|---|---|
| gq-insight | Health marker interpretation | 2.4 | Clinical board | Production |
| gq-assistant | Member Q&A | 1.9 | Clinical board | Production |
| gq-priority | Health priority score | 0.8 | Under review | Shadow |
| gq-recommend | Marketplace matching | 3.1 | Product + clinical | Production |
Insight review queue
Clinicians approve, edit or reject generated explanations.
“Your Vitamin D measured 18 ng/mL, below your personal baseline of 26 ng/mL. Four consecutive measurements have declined, alongside reduced daylight exposure recorded by your Oura ring.”
| Draft | Member | Type | Confidence | State |
|---|---|---|---|---|
| INS-88120 | Sarah Al Mansouri | Health marker | 0.86 | Awaiting review |
| INS-88121 | Omar Haddad | What changed | 0.91 | Approved |
| INS-88122 | Layla Nasser | Protocol | 0.88 | Approved |
Recommendation engine
Biology-to-action rules, transparent and editable.
| Rule | Condition | Recommends | Owner | State |
|---|---|---|---|---|
| Vitamin D low | 25-OH < 20 ng/mL | Protocol + D3/K2 + retest 18d | Clinical | Live |
| Zinc low | Zn < 70 µg/dL | Nutrition protocol + chelated zinc | Clinical | Live |
| LDL elevated | LDL > 130 mg/dL | Cardio protocol + omega-3 | Clinical | Review |
| Recovery decline | Recovery < baseline 6d | Sleep coaching offer | Product | Live |
Protocol library
Clinically authored programmes powering personalisation.
| Protocol | Trigger | Duration | Members active | Consistency |
|---|---|---|---|---|
| Optimize Vitamin D | Low 25-OH | 12 weeks | 3182 | 71% |
| Improve Recovery | Recovery below baseline | 8 weeks | 2410 | 64% |
| Cardiovascular Support | LDL elevated | 16 weeks | 1866 | 58% |
| Metabolic Reset | HbA1c trending | 12 weeks | 940 | 62% |
Digital Twin monitor
Data completeness and freshness across the member base.
Marketplace
3 screensMarketplace catalogue
Products tied to biology, not to banners.
| Product | Partner | Price | Margin | Linked health marker |
|---|---|---|---|---|
| Vitamin D3 + K2 | Nordic Labs | AED 149 | 42% | Vitamin D |
| Chelated Zinc | Thorne | AED 118 | 38% | Zinc |
| Omega-3 Triglyceride | Nordic Labs | AED 189 | 44% | LDL / hs-CRP |
| Sleep coaching | GenetiQ Partners | AED 890 | 55% | Recovery |
Partners & margins
Commercial governance of the ecosystem.
| Partner | Category | SKUs | GMV | Margin |
|---|---|---|---|---|
| Nordic Labs | Supplements | 22 | AED 284K | 43% |
| Thorne | Supplements | 18 | AED 196K | 38% |
| Oura | Wearables | 3 | AED 214K | 18% |
| GenetiQ Partners | Services | 11 | AED 167K | 55% |
Marketplace orders
Fulfilment and partner SLA tracking.
| Order | Member | Product | Value | State |
|---|---|---|---|---|
| MP-2214 | Sarah Al Mansouri | Vitamin D3 + K2 | AED 149 | Delivered |
| MP-2215 | Omar Haddad | Omega-3 | AED 189 | In transit |
| MP-2216 | Layla Nasser | Sleep coaching | AED 890 | Scheduled |
| MP-2217 | Hessa Al Suwaidi | Oura Ring Gen 4 | AED 1,499 | Delivered |
Growth
4 screensBusiness analytics
The commercial engine behind the intelligence platform.
Retention & retesting
Retesting is the compounding engine of the model.
| Cohort | Members | Retests due | Contacted | Converted |
|---|---|---|---|---|
| Vitamin D protocol | 3182 | 1120 | 1,120 | 742 |
| Cardio protocol | 1866 | 612 | 612 | 389 |
| Recovery protocol | 2410 | 806 | 790 | 504 |
Campaigns & CRM
Lifecycle messaging grounded in biology, not blasts.
| Campaign | Trigger | Channel | Sent | Conversion |
|---|---|---|---|---|
| Retest due | Protocol window | Push + WhatsApp | 2,538 | 58% |
| Founding member | Waitlist signup | 8,120 | 22% | |
| Wearable connect | No device linked | Push | 4,566 | 31% |
| Result explainer | Results published | In-app | 1,942 | 74% |
Corporate wellness
Employer programmes with aggregate-only reporting.
Note — Employers receive de-identified, aggregate cohort insight only. Individual results are never exposed.
Trust
5 screensSecurity center
Privacy-first architecture, continuously verified.
Audit log
Immutable record of every access to health data.
| Actor | Action | Subject | Time | Result |
|---|---|---|---|---|
| Dr. N. Haddad | Result approval | GQ-48219 | 14 Aug 09:12 | Allowed |
| LIMS service | Result import | BATCH-2292 | 14 Aug 06:40 | Allowed |
| gq-insight 2.4 | Insight generation | GQ-48219 | 14 Aug 09:20 | Allowed |
| Support agent | Clinical data view | GQ-48220 | 13 Aug 14:02 | Denied |
Roles & permissions
Separation of duties across clinical, lab and commercial teams.
| Role | Members | Clinical data | Financial | Admin |
|---|---|---|---|---|
| Clinical reviewer | 14 | Full | None | None |
| Lab technician | 32 | Sample scope | None | None |
| Collector | 46 | Schedule only | None | None |
| Support agent | 18 | Order context | Limited | None |
| Platform admin | 4 | None by default | Full | Full |
Compliance & governance
Built for regulated digital health from day one.
Note — GenetiQ provides health intelligence and education. It does not replace diagnosis or treatment by a licensed practitioner.
Support desk
Member experience with clinical escalation paths.
| Ticket | Member | Topic | Priority | State |
|---|---|---|---|---|
| SR-1182 | Sarah Al Mansouri | Retest scheduling | Normal | Open |
| SR-1183 | Omar Haddad | Marketplace delivery | Low | Resolved |
| SR-1184 | Layla Nasser | Result question | Clinical | Escalated |
| SR-1185 | Daniel Ferreira | Recollection | High | In progress |
42 operations screens · GenetiQ × Quick Digitals DMCC
